Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Efficacy of TECAR Therapy on Patient With Mechanical Neck Pain

19 maggio 2026 aggiornato da: Mohamed A. Abdel Ghafar, Batterjee Medical College

Influence of TECAR Therapy on Cervical Mobility and Functional Disability in Patients With Mechanical Neck Pain: Randomized Control Study

The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. It will also assess whether TECAR therapy provides additional clinical benefits compared with conventional physical therapy treatment. The main questions it aims to answer are:

  • Does TECAR therapy reduce pain intensity in patients with mechanical neck pain?
  • Does TECAR therapy improve cervical range of motion (CROM)?
  • Does TECAR therapy reduce functional disability as measured by the Neck Disability Index (NDI)? Researchers will compare participants receiving TECAR therapy combined with conventional physical therapy to participants receiving conventional physical therapy alone to determine the effectiveness of TECAR therapy in managing mechanical neck pain.

Participants will:

  • Attend scheduled treatment sessions during the study period
  • Receive either TECAR therapy with conventional physical therapy or conventional physical therapy alone
  • Undergo assessment of pain intensity, cervical range of motion, and neck disability before and after treatment

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Mechanical neck pain is one of the most common musculoskeletal disorders and is frequently associated with pain, restricted cervical mobility, and reduced functional performance, which may negatively affect daily activities and quality of life. Conventional physical therapy interventions are commonly used to manage mechanical neck pain; however, interest has recently increased in the use of TECAR therapy as a non-invasive modality that may enhance tissue healing, improve circulation, reduce pain, and restore function.

This single-blind randomized controlled trial aims to investigate the clinical effectiveness of TECAR therapy in individuals with mechanical neck pain. Participants who meet the eligibility criteria will be randomly assigned to either an experimental group receiving TECAR therapy in combination with conventional physical therapy or a control group receiving conventional physical therapy alone.

Outcome measures will be assessed before and after the intervention period and will include pain intensity, cervical range of motion (CROM), and functional disability using the Neck Disability Index (NDI). The study seeks to determine whether adding TECAR therapy to a conventional rehabilitation program provides superior improvements in pain reduction, cervical mobility, and functional outcomes in patients with mechanical neck pain.

Tipo di studio

Interventistico

Iscrizione (Stimato)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Mohamed A Abdel Ghafar, Ph.D.
  • Numero di telefono: 00966531513909
  • Email: Pt12.jed@bmc.edu.sa

Luoghi di studio

  • Arabia Saudita
    • Al Zahraa
      • Jeddah, Al Zahraa, Arabia Saudita, 23623
        • Saudi German Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Presence of neck pain for at least 3 months
  • Limited cervical range of motion associated with neck pain
  • Ability to understand and follow study instructions Willingness to participate and sign the informed consent form

Exclusion Criteria:

  • History of cervical spine surgery or fracture
  • Cervical radiculopathy or other neurological disorders
  • Presence of inflammatory, rheumatic, or systemic diseases affecting the cervical spine

Severe cervical disc prolapse or spinal instability Current participation in another treatment program for neck pain Pregnancy Presence of pacemakers, metal implants, or contraindications to TECAR therapy Skin disorders or open wounds in the treatment area

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: TECAR Therapy Group for Mechanical Neck Pain
Participants will receive TECAR therapy combined with a conventional physical therapy program for mechanical neck pain.
Dispositivo: TECAR
Participants in the TECAR group received TECAR therapy in capacitive and resistive modes targeting superficial and deep tissues of the affected area. Each session lasted 20-30 minutes, with intensity adjusted to produce a comfortable thermal effect without pain. TECAR therapy was applied three times/week for 12 weeks, alongside a standardized exercise program identical to the control group.
Altro: Conventional
Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.
Comparatore attivo: Conventional Physical Therapy Group for Mechanical Neck Pain
Participants will receive a conventional physical therapy program only.
Altro: Conventional
Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pain Intensity
Lasso di tempo: Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Pain intensity was measured using the Visual Analog Scale (VAS) to assess changes in neck pain intensity throughout the study period. The VAS is a self-reported pain assessment tool consisting of a 10-cm horizontal line, with scores ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity and therefore a worse outcome.
Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cervical Range of Motion (CROM)
Lasso di tempo: Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Measured using a Cervical Range of Motion device to evaluate changes in cervical flexion, extension, lateral flexion, and rotation.
Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Functional Disability
Lasso di tempo: Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Functional disability was measured using the Neck Disability Index (NDI) to assess changes in functional limitations associated with mechanical neck pain. The NDI is a self-administered questionnaire consisting of 10 items related to daily activities and pain. Each item is scored from 0 to 5, with a total score ranging from 0 to 50, where 0 indicates no disability and 50 indicates complete disability. Higher scores represent greater functional disability and therefore a worse outcome.
Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Batterjee Medical College

Collaboratori

Saudi German Hospital

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

7 giugno 2026

Completamento primario (Stimato)

15 settembre 2026

Completamento dello studio (Stimato)

10 ottobre 2026

Date di iscrizione allo studio

Primo inviato

13 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 maggio 2026

Primo Inserito (Effettivo)

19 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

19 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • BMCSGHTECAR

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su DOLORE MECCANICO ALLA SCHIENA

Prove cliniche su TECAR

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Burkina Faso

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi